Search for: "PREFERRED PHARMACEUTICALS, INC"
Results 1 - 20
of 431
Sorted by Relevance
|
Sort by Date
15 Oct 2017, 3:00 am
Gilead Pharmaceuticals, Inc., C.A. [read post]
8 Jul 2013, 6:30 am
©2013 Amaxx Risk Solutions, Inc. [read post]
1 Apr 2024, 10:58 am
Janssen Pharms., Inc. v. [read post]
15 Oct 2017, 3:00 am
Gilead Pharmaceuticals, Inc., C.A. [read post]
6 Sep 2010, 12:17 pm
©2010 Amaxx Risk Solutions, Inc. [read post]
9 Nov 2021, 5:04 pm
On November 9, the Department of Justice announced that Virginia-based pharmaceutical manufacturer Kaleo, Inc., has agreed to pay $12.7 million to settle fraud allegations, originally brought by a whistleblower, that the company steered physicians’ prescriptions to pharmacies kaléo Inc., a Virginia-based pharmaceutical manufacturer, has agreed to pay the United States $12.7 million to resolve allegations that kaléo caused the submission… [read post]
22 Oct 2009, 7:00 am
This decision is mostly based on individual preference in combination with the message provided by a commercial, billboard, or magazine advertisement. [read post]
31 Oct 2011, 12:21 pm
DFine was accused of using User Preference Evaluations (UPE) to induce physicians into using their products. [read post]
7 Jul 2008, 10:59 am
Wyeth Canada Inc., 2008 BCSC 847 (June 27, 2008). [read post]
21 Nov 2020, 5:56 am
The problem with pharmaceutical and biotech investments is that they typically involve a high degree of risk. [read post]
15 Dec 2011, 6:00 am
Stiefel Laboratories Inc is a subsidiary of pharmaceutical company GlaxoaSmithKline and was the world's largest private manufacturer of dermatology products. [read post]
4 Jun 2020, 10:10 am
In Ferring Pharmaceuticals Inc. et al v. [read post]
17 Oct 2014, 7:23 am
Sandoz, Inc., emphasizing that “[l]ast year’s patent decisions revealed a strong preference by the Supreme Court to tell the Federal Circuit that it should stop thinking of itself as Lord of the Patents, and that ‘supreme’ means just what it sounds like. [read post]
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
12 Jan 2011, 6:49 am
Benda Pharmaceutical Inc. et al., C.A. [read post]
22 Jan 2007, 7:41 am
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
24 Sep 2009, 10:38 am
Senator Charles Grassley, R-Iowa is continuing his probe of improper relationships between big pharmaceutical manufacturers and physicians. [read post]
19 Oct 2020, 4:37 pm
” DUSA Pharmaceuticals, Inc. v. [read post]
21 Jul 2011, 11:47 am
IMS Health Inc., found that speech to further pharmaceutical marketing is a form of expression protected by the First Amendment. [read post]
25 Nov 2012, 5:42 pm
Karst – A Complaint filed earlier this year by Mylan Pharmaceuticals Inc. [read post]
